KPTI - Karyopharm Therapeutics Inc.'s (KPTI) CEO Michael Kauffman on Q3 2019 Results - Earnings Call Transcript
Karyopharm Therapeutics Inc. (KPTI)
Q3 2019 Results Earnings Conference Call
November 04, 2019, 08:30 AM ET
Company Participants
Ian Karp - Vice President, Investor and Public Relations
Michael Kauffman - Chief Executive Officer
Sharon Shacham - President and Chief Scientific Officer
Mike Mason - Chief Financial Officer
Christopher Primiano - Chief Business Officer and General Counsel
Perry Monaco - Senior Vice President, Sales
Jatin Shah - Executive Vice President, Chief Medical Officer
Conference Call Participants
Brian Abrahams - RBC Capital Markets
Eric Joseph - JP Morgan
Jonathan Chang - Leerink Partners LLC
Maury Raycroft -